{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:28:17Z","timestamp":1792092497398,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:00:00Z","timestamp":1582848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FIS PI15\/01224"],"award-info":[{"award-number":["FIS PI15\/01224"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sirtuin 3 (SIRT3) is a deacetylase that modulates proteins that control metabolism and protects against oxidative stress. Modulation of SIRT3 activity has been proposed as a promising therapeutic target for ameliorating metabolic diseases and associated cardiac disturbances. In this study, we investigated the role of SIRT3 in inflammation and fibrosis in the heart using male mice with constitutive and systemic deletion of SIRT3 and human cardiac AC16 cells. SIRT3 knockout mice showed cardiac fibrosis and inflammation that was characterized by augmented transcriptional activity of AP-1. Consistent with this, SIRT3 overexpression in human and neonatal rat cardiomyocytes partially prevented the inflammatory and profibrotic response induced by TNF-\u03b1. Notably, these effects were associated with a decrease in the mRNA and protein levels of FOS and the DNA-binding activity of AP-1. Finally, we demonstrated that SIRT3 inhibits FOS transcription through specific histone H3 lysine K27 deacetylation at its promoter. These findings highlight an important function of SIRT3 in mediating the often intricate profibrotic and proinflammatory responses of cardiac cells through the modulation of the FOS\/AP-1 pathway. Since fibrosis and inflammation are crucial in the progression of cardiac hypertrophy, heart failure, and diabetic cardiomyopathy, our results point to SIRT3 as a potential target for treating these diseases.<\/jats:p>","DOI":"10.1038\/s41392-020-0114-1","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T19:06:10Z","timestamp":1582830370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation"],"prefix":"10.1038","volume":"5","author":[{"given":"Xavier","family":"Palomer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Silvia","family":"Rom\u00e1n-Azcona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pizarro-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Planavila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Villarroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Valenzuela-Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Crispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Sep\u00falveda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Miguel-Escalada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Francisco","family":"Nistal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7138-8207","authenticated-orcid":false,"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,28]]},"reference":[{"key":"114_CR1","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","volume":"168","author":"X Palomer","year":"2013","unstructured":"Palomer, X., Salvado, L., Barroso, E. & Vazquez-Carrera, M. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy. Int. J. Cardiol. 168, 3160\u20133172 (2013).","journal-title":"Int. J. Cardiol."},{"key":"114_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","volume":"375","author":"S Gupta","year":"2008","unstructured":"Gupta, S. et al. Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. J. Mol. Biol. 375, 637\u2013649 (2008).","journal-title":"J. Mol. Biol."},{"key":"114_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1385\/CT:3:3:229","volume":"3","author":"WK Jones","year":"2003","unstructured":"Jones, W. K. et al. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc. Toxicol. 3, 229\u2013254 (2003).","journal-title":"Cardiovasc. Toxicol."},{"key":"114_CR4","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/aps.2009.95","volume":"30","author":"M Wang","year":"2009","unstructured":"Wang, M. et al. Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway. Acta Pharm. Sin. 30, 1081\u20131091 (2009).","journal-title":"Acta Pharm. Sin."},{"key":"114_CR5","first-page":"H543","volume":"277","author":"MR Bergman","year":"1999","unstructured":"Bergman, M. R., Kao, R. H., McCune, S. A. & Holycross, B. J. Myocardial tumor necrosis factor-alpha secretion in hypertensive and heart failure-prone rats. Am. J. Physiol. 277, H543\u2013H550 (1999).","journal-title":"Am. J. Physiol."},{"key":"114_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/hc3101.093765","volume":"104","author":"SJ Stetson","year":"2001","unstructured":"Stetson, S. J. et al. Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha. Circulation 104, 676\u2013681 (2001).","journal-title":"Circulation"},{"key":"114_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.112.094524","volume":"126","author":"Z Pan","year":"2012","unstructured":"Pan, Z. et al. MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene\/transforming growth factor-beta1 pathway. Circulation 126, 840\u2013850 (2012).","journal-title":"Circulation"},{"key":"114_CR8","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1038\/sj.onc.1204385","volume":"20","author":"Y Chinenov","year":"2001","unstructured":"Chinenov, Y. & Kerppola, T. K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 20, 2438\u20132452 (2001).","journal-title":"Oncogene"},{"key":"114_CR9","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1002\/art.33501","volume":"64","author":"J Avouac","year":"2012","unstructured":"Avouac, J. et al. Inhibition of activator protein 1 signaling abrogates transforming growth factor beta-mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis Rheum. 64, 1642\u20131652 (2012).","journal-title":"Arthritis Rheum."},{"key":"114_CR10","doi-asserted-by":"publisher","first-page":"9793","DOI":"10.1073\/pnas.0802917105","volume":"105","author":"PT Pfluger","year":"2008","unstructured":"Pfluger, P. T. et al. Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl Acad. Sci. USA 105, 9793\u20139798 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"114_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2008.10.052","volume":"136","author":"TL Kawahara","year":"2009","unstructured":"Kawahara, T. L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62\u201374 (2009).","journal-title":"Cell"},{"key":"114_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20120030","volume":"444","author":"A Giralt","year":"2012","unstructured":"Giralt, A. & Villarroya, F. SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem. J. 444, 1\u201310 (2012).","journal-title":"Biochem. J."},{"key":"114_CR13","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1128\/MCB.01636-07","volume":"27","author":"DB Lombard","year":"2007","unstructured":"Lombard, D. B. et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27, 8807\u20138814 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"114_CR14","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1073\/pnas.0803790105","volume":"105","author":"BH Ahn","year":"2008","unstructured":"Ahn, B. H. et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl Acad. Sci. USA 105, 14447\u201314452 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"114_CR15","first-page":"2758","volume":"119","author":"NR Sundaresan","year":"2009","unstructured":"Sundaresan, N. R. et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119, 2758\u20132771 (2009).","journal-title":"J. Clin. Invest."},{"key":"114_CR16","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","volume":"285","author":"VB Pillai","year":"2010","unstructured":"Pillai, V. B. et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 285, 3133\u20133144 (2010).","journal-title":"J. Biol. Chem."},{"key":"114_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118909","volume":"10","author":"T Chen","year":"2015","unstructured":"Chen, T. et al. Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS ONE 10, e0118909 (2015).","journal-title":"PLoS ONE"},{"key":"114_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.freeradbiomed.2011.05.028","volume":"51","author":"T Koyama","year":"2011","unstructured":"Koyama, T. et al. SIRT3 attenuates palmitate-induced ROS production and inflammation in proximal tubular cells. Free Radic. Biol. Med. 51, 1258\u20131267 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"114_CR19","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1172\/JCI39366","volume":"119","author":"T Yoshizawa","year":"2009","unstructured":"Yoshizawa, T. et al. The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119, 2807\u20132817 (2009).","journal-title":"J. Clin. Invest."},{"key":"114_CR20","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1139\/cjpp-2015-0152","volume":"94","author":"C Koentges","year":"2016","unstructured":"Koentges, C. et al. Preserved recovery of cardiac function following ischemia-reperfusion in mice lacking SIRT3. Can. J. Physiol. Pharmacol. 94, 72\u201380 (2016).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"114_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ijcard.2014.03.176","volume":"174","author":"X Palomer","year":"2014","unstructured":"Palomer, X. et al. PPARbeta\/delta attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells. Int. J. Cardiol. 174, 110\u2013118 (2014).","journal-title":"Int. J. Cardiol."},{"key":"114_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/cvr\/cvn327","volume":"81","author":"X Palomer","year":"2009","unstructured":"Palomer, X. et al. TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model. Cardiovasc. Res. 81, 703\u2013712 (2009).","journal-title":"Cardiovasc. Res."},{"key":"114_CR23","doi-asserted-by":"publisher","first-page":"d804","DOI":"10.2741\/A323","volume":"3","author":"RA Hipskind","year":"1998","unstructured":"Hipskind, R. A. & Bilbe, G. MAP kinase signaling cascades and gene expression in osteoblasts. Front. Biosci. 3, d804\u2013d816 (1998).","journal-title":"Front. Biosci."},{"key":"114_CR24","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1128\/MCB.9.3.1327","volume":"9","author":"TM Fisch","year":"1989","unstructured":"Fisch, T. M., Prywes, R. & Roeder, R. G. An AP1-binding site in the c-fos gene can mediate induction by epidermal growth factor and 12-O-tetradecanoyl phorbol-13-acetate. Mol. Cell. Biol. 9, 1327\u20131331 (1989).","journal-title":"Mol. Cell. Biol."},{"key":"114_CR25","doi-asserted-by":"publisher","first-page":"5544","DOI":"10.3892\/mmr.2016.5942","volume":"14","author":"GD Chen","year":"2016","unstructured":"Chen, G. D., Yu, W. D. & Chen, X. P. SirT1 activator represses the transcription of TNFalpha in THP1 cells of a sepsis model via deacetylation of H4K16. Mol. Med. Rep. 14, 5544\u20135550 (2016).","journal-title":"Mol. Med. Rep."},{"key":"114_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jnc.13587","volume":"137","author":"J Yu","year":"2016","unstructured":"Yu, J., Wu, Y. & Yang, P. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects. J. Neurochem. 137, 371\u2013383 (2016).","journal-title":"J. Neurochem."},{"key":"114_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.plefa.2011.04.018","volume":"85","author":"E Dirkx","year":"2011","unstructured":"Dirkx, E. et al. High fat diet induced diabetic cardiomyopathy. Prostaglandins Leukot. Essent. Fatty Acids 85, 219\u2013225 (2011).","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"114_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00395-015-0493-6","volume":"110","author":"C Koentges","year":"2015","unstructured":"Koentges, C. et al. SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res. Cardiol. 110, 36 (2015).","journal-title":"Basic Res. Cardiol."},{"key":"114_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1128\/MCB.00586-15","volume":"36","author":"NR Sundaresan","year":"2015","unstructured":"Sundaresan, N. R. et al. SIRT3 blocks aging-associated tissue fibrosis in mice by deacetylating and activating glycogen synthase kinase 3beta. Mol. Cell. Biol. 36, 678\u2013692 (2015).","journal-title":"Mol. Cell. Biol."},{"key":"114_CR30","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/jcmm.12556","volume":"19","author":"H Zeng","year":"2015","unstructured":"Zeng, H. et al. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J. Cell. Mol. Med. 19, 1847\u20131856 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"114_CR31","doi-asserted-by":"publisher","first-page":"H424","DOI":"10.1152\/ajpheart.00454.2014","volume":"308","author":"T Chen","year":"2015","unstructured":"Chen, T. et al. Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-beta\/Smad3 pathway. Am. J. Physiol. Heart Circ. Physiol. 308, H424\u2013H434 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"114_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/jcmm.12453","volume":"19","author":"X Hou","year":"2015","unstructured":"Hou, X., Zeng, H., He, X. & Chen, J. X. Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes. J. Cell. Mol. Med. 19, 53\u201361 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"114_CR33","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","volume":"1863","author":"W Yu","year":"2017","unstructured":"Yu, W. et al. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of Foxo3A-Parkin-mediated mitophagy. Biochim. Biophys. Acta 1863, 1973\u20131983 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"114_CR34","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1101\/gad.1527307","volume":"21","author":"MB Scher","year":"2007","unstructured":"Scher, M. B., Vaquero, A. & Reinberg, D. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 21, 920\u2013928 (2007).","journal-title":"Genes Dev."},{"key":"114_CR35","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1128\/MCB.00426-08","volume":"28","author":"NR Sundaresan","year":"2008","unstructured":"Sundaresan, N. R. et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 28, 6384\u20136401 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"114_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbrc.2007.11.122","volume":"366","author":"Y Nakamura","year":"2008","unstructured":"Nakamura, Y., Ogura, M., Tanaka, D. & Inagaki, N. Localization of mouse mitochondrial SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. Biochem. Biophys. Res. Commun. 366, 174\u2013179 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"114_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1947601913483767","volume":"4","author":"P Martinez-Redondo","year":"2013","unstructured":"Martinez-Redondo, P. & Vaquero, A. The diversity of histone versus nonhistone sirtuin substrates. Genes Cancer 4, 148\u2013163 (2013).","journal-title":"Genes Cancer"},{"key":"114_CR38","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.bbalip.2014.05.007","volume":"1841","author":"BL Caputto","year":"2014","unstructured":"Caputto, B. L., Cardozo Gizzi, A. M. & Gil, G. A. c-Fos: an AP-1 transcription factor with an additional cytoplasmic, non-genomic lipid synthesis activation capacity. Biochim. Biophys. Acta 1841, 1241\u20131246 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"114_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124744","volume":"10","author":"M Kim","year":"2015","unstructured":"Kim, M. et al. SIRT3 overexpression attenuates palmitate-induced pancreatic beta-cell dysfunction. PLoS ONE 10, e0124744 (2015).","journal-title":"PLoS ONE"},{"key":"114_CR40","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3760\/cma.j.issn.0366-6999.20132975","volume":"127","author":"Y Song","year":"2014","unstructured":"Song, Y. et al. Metformin ameliorates insulin resistance in L6 rat skeletal muscle cells through upregulation of SIRT3. Chin. Med. J. 127, 1523\u20131529 (2014).","journal-title":"Chin. Med. J."},{"key":"114_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/endo.134.1.8275944","volume":"134","author":"AL Olson","year":"1994","unstructured":"Olson, A. L. & Pessin, J. E. Regulation of c-fos expression in adipose and muscle tissue of diabetic rats. Endocrinology 134, 271\u2013276 (1994).","journal-title":"Endocrinology"},{"key":"114_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.molcel.2011.07.019","volume":"44","author":"MD Hirschey","year":"2011","unstructured":"Hirschey, M. D. et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44, 177\u2013190 (2011).","journal-title":"Mol. Cell"},{"key":"114_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/cvr\/cvq080","volume":"87","author":"D \u00c1lvarez-Guardia","year":"2010","unstructured":"\u00c1lvarez-Guardia, D. et al. The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells. Cardiovasc. Res. 87, 449\u2013458 (2010).","journal-title":"Cardiovasc. Res."},{"key":"114_CR44","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.ijcard.2012.06.006","volume":"167","author":"X Palomer","year":"2013","unstructured":"Palomer, X. et al. Resveratrol induces nuclear factor-kappaB activity in human cardiac cells. Int. J. Cardiol. 167, 2507\u20132516 (2013).","journal-title":"Int. J. Cardiol."},{"key":"114_CR45","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1242\/dmm.020768","volume":"8","author":"X Palomer","year":"2015","unstructured":"Palomer, X. et al. miR-146a targets c-Fos expression in human cardiac cells. Dis. Models Mech. 8, 1081\u20131091 (2015).","journal-title":"Dis. Models Mech."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0114-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0114-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0114-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T02:40:09Z","timestamp":1722480009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-020-0114-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1038\/s41392-020-0114-1","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,28]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}